We are live on ! Find out more
ACH

Accendra Health

168 hedge funds and large institutions have $193M invested in Accendra Health in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 54 increasing their positions, 67 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $1.14M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.87% less ownership

Funds ownership: 94.07%89.21% (-4.9%)

17% less funds holding

Funds holding: 202168 (-34)

19% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 67

45% less capital invested

Capital invested by funds: $349M → $193M (-$156M)

54% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 54

Holders
168
Holders Change
-34
Holders Change %
-16.83%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
25
Increased
54
Reduced
67
Closed
54
Calls
$1.48M
Puts
$1.14M
Net Calls
+$337K
Net Calls Change
+$358K

ACH Hedge Fund Activity: Q4 2025 in Review

168 of the 8,257 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q4 2025, worth a combined $193M — down 45% from $349M a quarter earlier.

Sellers outnumbered buyers: 54 funds closed out of ACH and 25 opened new positions — a net loss of 29 holders — while 67 trimmed existing stakes and 54 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $4.43M. The largest seller was Towle & Co, exiting entirely with an estimated $5.99M sold.

  • 168 institutional investors held Accendra Health (ACH) as of Q4 2025, down from 202 in Q3 2025.
  • Funds reported $193M of Accendra Health stock for Q4 2025, down 45% quarter-over-quarter.
  • 25 funds opened new Accendra Health positions in Q4 2025 and 54 closed out, a net change of -29 holders.
  • The largest Accendra Health buyer in Q4 2025 was D.E. Shaw & Co, an estimated $4.43M added.
  • The largest Accendra Health seller in Q4 2025 was Towle & Co, an estimated $5.99M sold.

Based on aggregated 13F filings for Q4 2025.